Friday, 12 October 2018

Nanoparticles show promise in treatment for triple-negative breast cancer

Researchers have found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer. Doxorubicin is a well-known anthracycline drug class used primarily in combination chemotherapy

No comments:

Post a Comment

Novel smart probe may improve post-surgical outcomes for cancer patients

In cases of #melanoma and #breast cancer, for example, the #surgeon may believe he/she has gotten everything -- that he/she has excised the...